TREE NEWS reports: Moderna (MRNA) fell over 4.3% to $144.30, holding near highs since an August 19 surge of 177%. Rothschild & Co. said the company is now overvalued following a rally driven by cancer vaccine prospects.
Moderna falls 4.3% to $144.30 after Rothschild says overvalued
Share on WeChat
Open WeChat → Scan → then tap "…" to send to a chat or Moments.
Tap "…" in the top-right corner to send to a chat or share to Moments.
Related News
2h ago
US Judge Allows Pentagon to Fire Three Stars and Stripes Journalists
3h ago
Coatue in talks with MatX on chip-financing JV
3h ago
DoubleLine credit chief sees value in big tech bonds after AI selloff
4h ago
Anthropic to File IPO Prospectus in Late September
4h ago
Meta sued over smart glasses biometric data collection
4h ago
US stock futures mixed at Friday close; Dow leads decline